Various studies have highlighted that nuclear transport receptors including XPO1, KPNA2, and KPNA4, exhibit hyperactivity in cancer and facilitate the export of vital tumor suppressors to the cytoplasm [39] or the import of oncogenes to the nucleus [40]. This evidence concerns the gene KPNA2 and neoplasm.